Multithread effectively and personalize outreach to convert deals faster
Elevate social presence and drive business growth from social media
Identify and prioritize high-intent leads, and improve sales effectiveness
Find and connect with ICP attendees, and improve event outcomes
Outset Medical, Inc. is a rapidly growing medical technology company dedicated to reducing the cost and complexity of dialysis. Their flagship product, the Tablo® Hemodialysis System, is an FDA-cleared, all-in-one enterprise solution designed for use across the continuum of care, from hospital to home. Tablo aims to simplify dialysis treatment for patients and providers, offering automated self-service features, integrated water purification, and real-time data reporting. Outset Medical is focused on improving patient outcomes and experiences while transforming the dialysis care model.
The San Jose headquarters serves as the central hub for research and development, corporate operations, strategic planning, engineering, and administrative functions.
The facility is likely a modern, purpose-built space designed to foster innovation and collaboration, featuring advanced R&D labs and open office environments suitable for a high-tech medical device company.
Outset Medical's work culture is characterized by a strong emphasis on innovation, patient-centricity, collaboration, and a fast-paced environment. Employees are driven by the mission to improve the lives of dialysis patients.
Its Silicon Valley location provides access to a rich talent pool in engineering, software development, and medical technology, as well as proximity to venture capital and a network of industry partners.
Outset Medical's primary market focus is currently the United States, where the Tablo Hemodialysis System is FDA-cleared. While direct international office presence is limited, the company supports its U.S. operations through global supply chain partners and may explore international market expansion in the future. Their global functions currently revolve around sourcing, logistics, and potential regulatory exploration for new markets.
3052 Orchard Drive
San Jose
CA
USA
Address: N/A - Distributed field teams
To provide localized sales, training, clinical support, and technical service for the Tablo Hemodialysis System to hospitals, clinics, and home dialysis patients across different regions of the United States.
Highperformr Signals uncover buying intent and give you clear insights to target the right accounts at the right time — helping your sales, marketing, and GTM teams close more deals, faster.
As of April 2025, Outset Medical, Inc.' leadership includes:
Outset Medical, Inc. has been backed by several prominent investors over the years, including:
Outset Medical has seen some key executive movements aimed at strengthening its commercial and medical leadership. Notably, a new Chief Commercial Officer joined in late 2023, and a new Chief Medical Officer was appointed in early 2024.
Discover the tools Outset Medical, Inc. uses. Highperformr reveals the technologies powering your target accounts — helping your sales, marketing, and GTM teams prioritize smarter and close faster.
Outset Medical commonly utilizes the [firstinitial][last]@outsetmedical.com email format (e.g., jsmith@outsetmedical.com). Other less common formats might exist but this is the most prevalent.
[first_initial][last]@outsetmedical.com
Format
ltrigg@outsetmedical.com
Example
80%
Success rate
Outset Medical, Inc. IR • May 8, 2024
Outset Medical announced its financial results for the first quarter ended March 31, 2024, reporting total revenue of $30.0 million. The company highlighted progress on its initiatives to drive Tablo adoption in the home market and manage operating expenses....more
Business Wire • March 7, 2024
Outset Medical announced it would showcase TabloCORE, a new informatics solution for acute care settings, at the American Medical Informatics Association (AMIA) 2024 Informatics Summit. TabloCORE is designed to provide clinicians with actionable insights from Tablo hemodialysis treatments....more
Outset Medical, Inc. IR • January 8, 2024
Outset Medical announced the appointment of Michael Aragon, M.D., as Chief Medical Officer, effective January 8, 2024. Dr. Aragon brings extensive experience in clinical development and medical affairs to the company....more
See where a company’s workforce is located, by country or region.
View past and recent funding rounds with amounts and investors.
Understand company revenue estimates and financial scale.
Track active roles and hiring trends to spot growth signals.
Discover what a company offers—products, platforms, and solutions.
Get the company’s official SIC and NAICS classifications.
Analyze visitor volume, engagement, and top traffic sources.
Explore LinkedIn, Twitter, and other active social profiles.
Identify top competitors based on similar business traits.
Explore companies in depth — from the tech they use to recent funding, hiring trends, and buyer signals — all in one powerful view.
Highperformr AI helps you surface the right accounts and enrich your CRM with verified company and contact insights, so your teams can prioritize and engage faster.
Thousands of companies, including Outset Medical, Inc., are just a search away.